Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia

Drug and Alcohol Review

Volumn 25, Issue 5, 2006, Pages 445-449

  Kinner, Stuart A ^a   Degenhardt, Louisa ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Early warning system; Ecstasy; Monitoring; Surveillance

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADDICTION; AUSTRALIA; COMMERCIAL PHENOMENA; HEALTH SURVEY; HUMAN; INCIDENCE; MANDATORY REPORTING; METHODOLOGY; PREVALENCE; REVIEW; STATISTICS; SUBSTANCE ABUSE; TIME;

AUSTRALIA; COMMERCE; HUMANS; INCIDENCE; MANDATORY REPORTING; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POPULATION SURVEILLANCE; PREVALENCE; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 33750125061     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230600876705     Document Type: Review

References (24)

1. Griffiths P, Vingoe L, Hunt N, Mounteney J, Hartnoll R. Drug information systems, early warning, and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption? Subst Use Misuse 2000;35:811-44.
2. Degenhardt L, Day C, Hall W, eds. The causes, course and consequences of the heroin shortage in Australia. NDLERF Monograph no. 3. Adelaide: Australasian Centre for Policing Research, 2004.
3. Degenhardt L, Stafford J, Kinner S, Johnston J, Agaliotis M, Fry C. Reflections on a two-year national pilot study of the Party Drugs Initiative (PDI). NDARC Technical Report no. 236. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2005.
4. Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend 2003;70:275-86.
5. Hando J, Darke S, O'Brien S, Maher L, Hall W. The development of an early warning system to detect trends in illicit drug use in Australia: the Illicit Drug Reporting System. Addict Res 1998;6:97-113.
6. Single E, Rohl T. The national drug strategy: mapping the future. An evaluation of the national drug strategy 1993 - 1997. Canberra: Australian Government Publishing Services, 1997.
7. United Nations Office on Drugs and Crime. 2004 World drug report. Geneva: United Nations, 2004.
8. Griffiths P, Vingoe L, Jansen K, et al. New trends in synthetic drugs in the European Union: epidemiology and demand reduction responses. EMCDDA Insights series 1. Luxembourg: Office for Official Publications of the European Union, 1997.
9. Stafford J, Degenhardt L, Black E. Australian Drug Trends 2004: findings from the Illicit Drug Reporting System (IDRS). October 2004 drug trends bulletin. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2004.
10. Topp L, Degenhardt L, Kaye S, Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. Drug Alcohol Rev 2002;21:341-8.
11. Farrell M, Marsden J, Ali R, Ling W. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 2002;97:771-2.
12. Gibson D, Leamon M, Flynn N. Epidemiology and public health consequences of methamphetamine use in California's Central Valley. J Psychoact Drugs 2002;34:313-19.
13. Australian Institute of Health and Welfare. 2004 National drug strategy household survey: first results. Canberra: Australian Institute of Health and Welfare, 2005.
14. Breen C, Topp L, Longo M. Adapting the IDRS methodology to monitor trends in party drug markets: findings of a two-year feasibility trial. NDARC Technical Report no. 142. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2002.
15. Topp L, Breen C, Kaye S, Darke S. Adapting the Illicit Drug Reporting System (IDRS) methodology to examine the feasibility of monitoring trends in party drug markets. Drug Alcohol Depend 2004;73:189-97.
16. Breen C, Degenhardt L, White B, et al. Australian party drug trends 2003: findings from the Party Drugs Initiative (PDI). NDARC Monograph 52. Sydney: National Drug and Alcohol Research Centre, University of NSW, 2004.
17. Stafford J, Degenhardt L, Agaliotis M, et al. Australian trends in ecstasy and related drug markets 2004: findings from the Party Drugs Initiative (PDI). NDARC Monograph no. 57. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2005.
18. Parker H, Williams L, Aldridge J. The normalization of 'sensible' recreational drug use: further evidence from the North West England longitudinal study. Sociology 2002;36: 941-64.
19. Kinner S, Fowler G, Fischer J, Stafford J, Degenhardt L. Monitoring the ecstasy market in Australia-challenges and successes. April 2005 party drug trends bulletin. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2005.
20. Kerlinger FN. Foundations of behavioral research, 3rd edn. Japan: CBS Publishing Limited, 1986.
21. Degenhardt L, Barker B, Topp L. Patterns of ecstasy use in Australia: findings from a national household survey. Addiction 2004;99:187-95.
22. Kelly E, McKetin R, McLaren J. Health service utilisation associated with methamphetamine use. NDARC Technical Report no. 233. Sydney: National Drug and Alcohol Research Centre, University of NSW, 2005.
23. NSW Health. Drinkcheck: a manual for alcohol brief intervention in health and community settings. Sydney: Northern Rivers Area Health Service, NSW Health, 2000.
24. Australian Crime Commission. Australian illicit drug report 2003 - 04. Canberra: Australian Crime Commission, 2005.